These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3370065)

  • 1. Assessment of intracellular sodium and calcium in essential hypertension during diuretic treatment.
    Spieker C; Zidek W; Häcker W; Schmidt W; Vetter H
    Arzneimittelforschung; 1988 Jan; 38(1A):188-90. PubMed ID: 3370065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.
    Spannbrucker N; Achhammer I; Metz P; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
    Klütsch K; Grosswendt J; Haecker W
    Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects of torasemide prolonged release in mild-to-moderate hypertension: a randomized noninferiority trial versus torasemide immediate release.
    Roca-Cusachs A; Aracil-Vilar J; Calvo-Gómez C; Vaquer-Pérez JV; Laporta-Crespo F; Rojas-Serrano MJ; Guglietta A; Gropper S;
    Cardiovasc Ther; 2008; 26(2):91-100. PubMed ID: 18485132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular electrolytes during antihypertensive treatment with a loop diuretic.
    Zidek W; Losse H; Schmidt W; Fehske KJ; Vetter H
    J Hypertens; 1984 Aug; 2(4):393-5. PubMed ID: 6530547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacodynamics of torasemide and furosemide in patients with oedema.
    Herchuelz A; Deger F; Douchamps J; Ducarne H; Broekhuysen J
    Arzneimittelforschung; 1988 Jan; 38(1A):180-3. PubMed ID: 3285831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular calcium in essential hypertension. A parameter for assessing effective antihypertensive treatment.
    Zidek W; Baumgart P; Karoff C; Losse H; Vetter H
    J Hypertens Suppl; 1984 Dec; 2(3):S495-7. PubMed ID: 6599706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formal comparison of the antihypertensive effects of torasemide and other diuretics by the Montevideo mathematical model.
    Reyes AJ
    Arzneimittelforschung; 1988 Jan; 38(1A):194-9. PubMed ID: 3370066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of torasemide in congestive heart failure and essential hypertension.
    Brater DC
    Drug Saf; 1996 Feb; 14(2):104-20. PubMed ID: 8852525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torasemide, a new loop diuretic, in patients with chronic renal failure.
    Russo D; Gazzotti RM; Testa A
    Nephron; 1990; 55(2):141-5. PubMed ID: 2194134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Torasemide is the effective loop diuretic for long-term therapy of arterial hypertension].
    Preobrazhenskiĭ DV; Nekrasova NI; Khoseva EN; Arystanova A; Talyzina IV; Pataraia SA
    Kardiologiia; 2011; 51(4):67-73. PubMed ID: 21623723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of torasemide in patients with chronic heart failure.
    Achhammer I; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):184-7. PubMed ID: 3285832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronotherapy with torasemide in hypertensive patients: increased efficacy and therapeutic coverage with bedtime administration].
    Calvo C; Hermida RC; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Soler R; Fontao MJ; Fernández JR
    Med Clin (Barc); 2006 Nov; 127(19):721-9. PubMed ID: 17198647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive efficacy of low dose torasemide in essential hypertension: a placebo-controlled study.
    Dupont AG; Schoors D; Six RO; Vanhaelst L
    J Hum Hypertens; 1988 Dec; 2(4):265-8. PubMed ID: 3236329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.
    Meywald W; Maass L; Verho M; Rangoonwala B
    Pharmatherapeutica; 1985; 4(6):356-66. PubMed ID: 4080753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
    Mourad G; Haecker W; Mion C
    Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.
    Stroobandt R; Dodion L; Kesteloot H
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):151-8. PubMed ID: 6762167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
    Brunner G; von Bergmann K; Häcker W; von Möllendorff E
    Arzneimittelforschung; 1988 Jan; 38(1A):176-9. PubMed ID: 3285830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerance of low-dose loop diuretics in hypertension.
    Schmieder RE; Rockstroh JK
    Cardiology; 1994; 84 Suppl 2():36-42. PubMed ID: 7954543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.